The Business Research Company’s report on the GI Stool Testing Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the gi stool testing market?
The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the GI stool testing market going forward. Gastrointestinal disorders refer to conditions affecting the digestive system, including the stomach, intestines, and related organs, causing symptoms such as nausea, diarrhea, constipation, and abdominal pain. The rise in gastrointestinal disorders is largely due to poor dietary habits, as increased consumption of processed foods, high sugar intake, and low-fiber diets disrupt gut microbiota, weaken digestive health, and contribute to conditions such as acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is required for gastrointestinal disorders to detect infections, inflammation, or digestive imbalances, as it helps identify pathogens (bacteria, viruses, parasites), markers of gut inflammation, and digestive enzyme deficiencies, enabling accurate diagnosis and targeted treatment. For instance, in September 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that between 2024 and 2025, NoroSTAT-participating states reported 1,676 norovirus outbreaks, marking a significant rise from the 729 outbreaks recorded during the same period last season. Therefore, the increasing prevalence of gastrointestinal disorders drives the growth of the GI stool testing market.
Rising Healthcare Infrastructure Penetration Driving Growth In The Market Due To Enhanced Accessibility And Early Disease Detection
The increasing penetration of healthcare infrastructure is expected to propel the growth of the GI stool testing market going forward. Healthcare infrastructure refers to the physical, technological, and organizational facilities required to deliver medical services, including hospitals, clinics, equipment, and digital health systems. The rise in healthcare infrastructures is driven by a growing population and aging demographics, as increasing life expectancy and higher disease prevalence demand more hospitals, clinics, and advanced medical facilities to ensure adequate healthcare access and improved patient outcomes. The expansion of healthcare infrastructures enhances the accessibility and accuracy of GI stool testing, as improved laboratory facilities, advanced diagnostic technologies, and better-trained medical professionals enable faster, more precise detection of gastrointestinal disorders, leading to timely treatment and better patient outcomes. For instance, in November 2024, according to The Health Foundation, a UK-based independent charity, the Department of Health and Social Care (DHSC) spending is projected to rise from $227.6 billion in 2023/24 to $238.6 billion in 2024/25 and $250.6 billion in 2025/26, indicating an average annual real-term growth of 3.3%. Therefore, the increasing penetration of healthcare infrastructure drives the growth of the GI stool testing market.
Access Your Free Sample of the Global GI Stool Testing Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=23410&type=smp
How has the gi stool testing market size evolved, and what are the latest forecasts for its expansion?
The GI stool testing market size has grown strongly in recent years. It will grow from $1.32 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal diseases, increasing awareness of gut health, increasing adoption of automated systems, growing disposable income, growing geriatric population.
The GI stool testing market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing need for efficient diagnostic instruments, increasing prevalence of colorectal cancer, rising healthcare expenditure, rising consumption of fast food, growing emphasis on personalized medicine. Major trends in the forecast period include innovative diagnostic technologies, molecular diagnostics, advancements in biologics, personalized medicine, strategic collaboration.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=23410&type=smp
Which major companies dominate the gi stool testing market?
Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG.
What are the major trends in the gi stool testing market?
Major companies operating in the GI stool testing market are focusing on advanced testing technologies, such as comprehensive diagnostic tests, to improve accuracy, speed, and early disease detection. A comprehensive diagnostic test is an advanced medical tool that evaluates multiple health parameters simultaneously, offering a thorough assessment of a condition. For instance, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test developed to support healthcare providers in identifying gastrointestinal disorders. This cutting-edge test utilizes a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disruptions. With a 24-hour turnaround time, GI Detect enables fast and informed clinical decision-making. In addition to broad pathogen detection, the test also screens for Helicobacter pylori and its virulence factors—VacA, cagA, and babA—as well as common gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive approach ensures accurate and timely diagnosis of gastrointestinal infections.
Which region dominates the gi stool testing market, and what factors contribute to its leadership?
North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report
How is the gi stool testing market segmented, and which segment holds the largest share?
The gi stool testing market covered in this report is segmented –
1) By Type: Immunoassay Test, Molecular Diagnostic Test, Chromatography-Based Test, Microbiological Culture Test, Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Sample Type: Fecal Samples, Serum Samples
3) By Equipment: Automated Analyzers, Benchtop Instruments, Portable Devices
4) By Application: Diagnosis Of Gastrointestinal Disorders, Screening For Colorectal Cancer, Monitoring Of Inflammatory Bowel Disease (IBD), Detection Of Gastrointestinal Infections, Evaluation Of Digestive Health
5) By End User: Hospital, Diagnostic Centre And Laboratory, Academic Institution, Research Centre Organization, Homecare, Other End Users
Subsegments:
1) By Immunoassay Test: Rapid Immunoassay, Lateral Flow Assay, Fluorescent Immunoassay
2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Test (NAAT), Next-Generation Sequencing (NGS)
3) By Chromatography-Based Test: Gas Chromatography (GC), Liquid Chromatography (LC), Thin-Layer Chromatography (TLC)
4) By Microbiological Culture Test: Aerobic Culture, Anaerobic Culture, Selective Media Culture
5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23410
What defines the structure and scope of the gi stool testing market?
Gastrointestinal (GI) stool testing refers to the analysis of stool samples to assess gastrointestinal health and detect infections, digestive disorders, and inflammatory conditions. It helps identify microbial imbalances, digestive enzyme deficiencies, and markers of gut inflammation. This non-invasive diagnostic method supports early disease detection and personalized treatment planning.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
